The elevated expression of both anti-C5aR and anti-C3aR via the immunohistochemistrical analysis of OCCC with statistically significance was noted, and this may imply that the complement system has a dual action as a promotor or controller in cancer. This evidence concerns the gene C3AR1 and cancer.